It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3383
[] Institution:Study Staff Contact – [3383] Trial:A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy